Conservative Management of Retroperitoneal Ectopic Pregnancy by Computed Tomographic-guided Methotrexate Injection in the Gestational Sac: 2 Case Reports and Literature Review

J Minim Invasive Gynecol. 2019 Sep-Oct;26(6):1187-1192. doi: 10.1016/j.jmig.2018.12.016. Epub 2019 Jan 4.

Abstract

Retroperitoneal ectopic pregnancy (REP) is an extremely rare type of ectopic pregnancy. Currently, surgery is the most widely used treatment method although it involves a high likelihood of intraoperative hemorrhage. In this case report, we describe a safe and effective alternative method for managing epigastric REP. We conducted a retrospective analysis of the clinical data of 2 patients with REP in the epigastrium who were treated at our hospital using our nonsurgical method. The treatment involved conservative management by computed tomographic-guided methotrexate injection in the gestational sac. We also present a literature review of 26 case reports and discuss the clinical features and various methods for treating REP. Our experience with the successful treatment of 2 patients suggests that the novel approach of computed tomographic-guided methotrexate injection in the gestational sac may be a safe and effective approach to manage REP. Further studies are warranted to confirm our findings.

Keywords: Computed tomographic–guided injection; Methotrexate; Retroperitoneal ectopic pregnancy.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Abortifacient Agents, Nonsteroidal / administration & dosage
  • Adult
  • Blood Loss, Surgical
  • China
  • Conservative Treatment / methods
  • Female
  • Gestational Sac
  • Humans
  • Injections, Intraperitoneal / methods
  • Methotrexate / administration & dosage*
  • Pregnancy
  • Pregnancy, Ectopic / diagnosis*
  • Pregnancy, Ectopic / drug therapy*
  • Radiography, Interventional / methods*
  • Retroperitoneal Space / diagnostic imaging
  • Retroperitoneal Space / pathology
  • Tomography, X-Ray Computed*

Substances

  • Abortifacient Agents, Nonsteroidal
  • Methotrexate